These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20460510)

  • 1. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.
    Adhikari AS; Agarwal N; Wood BM; Porretta C; Ruiz B; Pochampally RR; Iwakuma T
    Cancer Res; 2010 Jun; 70(11):4602-12. PubMed ID: 20460510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of osteosarcoma stem cells by chemotherapy.
    Tang QL; Liang Y; Xie XB; Yin JQ; Zou CY; Zhao ZQ; Shen JN; Wang J
    Chin J Cancer; 2011 Jun; 30(6):426-32. PubMed ID: 21627865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9.
    Zhao F; Lv J; Gan H; Li Y; Wang R; Zhang H; Wu Q; Chen Y
    Int J Clin Exp Pathol; 2015; 8(2):1451-8. PubMed ID: 25973030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma.
    Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
    J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells.
    Yang M; Yan M; Zhang R; Li J; Luo Z
    Cancer Sci; 2011 Oct; 102(10):1774-81. PubMed ID: 21740477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
    Roundhill EA; Jabri S; Burchill SA
    Cancer Lett; 2019 Jul; 453():142-157. PubMed ID: 30910588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.
    Chen J; Wang J; Chen D; Yang J; Yang C; Zhang Y; Zhang H; Dou J
    BMC Cell Biol; 2013 Jan; 14():7. PubMed ID: 23368632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
    Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
    Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.
    Natarajan A; Ramachandran B; Gopisetty G; Jayavelu S; Sundersingh S; Rajkumar T
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):361-371. PubMed ID: 33015747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
    Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
    Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
    Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
    Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line.
    Mealey KL; Barhoumi R; Rogers K; Kochevar DT
    Cancer Lett; 1998 Apr; 126(2):187-92. PubMed ID: 9585065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stro-1(+) stromal cells have stem-like features in giant cell tumor of bone.
    Lan J; Liu X; Rong W; Wei F; Jiang L; Yu H; Dang G; Liu Z
    J Surg Oncol; 2012 Dec; 106(7):826-36. PubMed ID: 22605660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
    Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
    Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.